![Kenneth Hitchner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 3 M $ al 30/09/2026
Mr. Kenneth W.
Hitchner is an Independent Non-Executive Director at WuXi XDC Cayman, Inc., a Chairman at Sphere Bio Ltd., a Chairman at Cydar Ltd., a Chairman at HH&L Acquisition Co. and an Independent Non-Executive Director at WuXi Biologics (Cayman), Inc. He is on the Board of Directors at WuXi XDC Cayman, Inc., CStone Pharmaceuticals Co. Ltd. and WuXi Biologics (Cayman), Inc. Mr. Hitchner was previously employed as an Independent Director by Provident Acquisition Corp., a Chairman & Chief Executive Officer by Goldman Sachs (Asia) LLC, a Chairman & Chief Executive Officer by Goldman Sachs Asia LLC (Alternative Investment), a Member-Healthcare Banking Group by The Goldman Sachs Group, Inc., a Professor by Columbia Business School, a Trustee by Hackensack Meridian Health, Inc., and a Vice Chairman by Meridian Health System, Inc. He received his undergraduate degree from The University of Colorado and an MBA from Columbia Business School.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CSTONE PHARMACEUTICALS 0,16 % | 08/06/2026 | 2.513.481 ( 0,16 % ) | 2 M $ | 30/09/2026 |
| 31/12/2025 | 203.205 ( 0 % ) | 1 M $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| WUXI BIOLOGICS (CAYMAN) INC. | Director/Miembro de la Junta | 09/06/2020 |
| HH&L ACQUISITION CO. | Presidente | 11/02/2021 |
| CSTONE PHARMACEUTICALS | Director/Miembro de la Junta | 10/12/2021 |
| WUXI XDC CAYMAN INC. | Director/Miembro de la Junta | 21/11/2024 |
Cydar Ltd.
 Cydar Ltd. Packaged SoftwareTechnology Services Develops computer vision software applications | Presidente | 14/02/2023 |
Sphere Fluidics Ltd.
 Sphere Fluidics Ltd. BiotechnologyHealth Technology Develops technology platform for single cell analysis and characterization | Presidente | 02/05/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
| PROT ACQU | Director/Miembro de la Junta | 28/10/2022 |
Goldman Sachs (Asia) LLC
 Goldman Sachs (Asia) LLC Investment Banks/BrokersFinance Provides brokerage services | Director Ejecutivo | 12/07/2019 |
Goldman Sachs Asia LLC (Alternative Investment)
 Goldman Sachs Asia LLC (Alternative Investment) Investment ManagersFinance GS Asia-AI is an active, opportunistic, multi-disciplinary manager which follows an intensive fundamental approach to investing. They seek asymmetric risk-reward opportunities, aiming to achieve equity-like returns. The firm utilizes their cross-market capabilities to capture synergies across the capital structure in both public and private markets. | Director Ejecutivo | 12/07/2019 |
| ░░░ ░░░░░░░ ░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 14 |
|---|---|
The Goldman Sachs Group, Inc.
 The Goldman Sachs Group, Inc. Investment Banks/BrokersFinance Provides investment banking, asset, wealth management and platform services | Finance |
The University of Colorado
 The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Meridian Health System, Inc.
 Meridian Health System, Inc. Medical/Nursing ServicesHealth Services Operates as a not-for-profit health care organization | Health Services |
Goldman Sachs (Asia) LLC
Goldman Sachs (Asia) LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Sphere Fluidics Ltd.
Sphere Fluidics Ltd. BiotechnologyHealth Technology Develops technology platform for single cell analysis and characterization | Health Technology |
Goldman Sachs Asia LLC (Alternative Investment)
Goldman Sachs Asia LLC (Alternative Investment) Investment ManagersFinance GS Asia-AI is an active, opportunistic, multi-disciplinary manager which follows an intensive fundamental approach to investing. They seek asymmetric risk-reward opportunities, aiming to achieve equity-like returns. The firm utilizes their cross-market capabilities to capture synergies across the capital structure in both public and private markets. | Finance |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hackensack Meridian Health, Inc.
 Hackensack Meridian Health, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization that provides primary, cancer care and orthopedic services | Commercial Services |
Cydar Ltd.
Cydar Ltd. Packaged SoftwareTechnology Services Develops computer vision software applications | Technology Services |
CStone Pharmaceuticals Co. Ltd.
 CStone Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutic treatments for oncology, cardiovascular diseases, rheumatoid arthritis, hematology and autoimmune diseases | Health Technology |
Wuxi Biologics (Cayman), Inc.
 Wuxi Biologics (Cayman), Inc. BiotechnologyHealth Technology Engages in discovery, development and manufacturing of biologics | Health Technology |
Provident Acquisition Corp.
 Provident Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
HH&L Acquisition Co.
 HH&L Acquisition Co. Financial ConglomeratesFinance Operates as a blank check company | Finance |
WuXi XDC Cayman, Inc.
 WuXi XDC Cayman, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a holding company that provides contract, research, development and manufacturing services | Commercial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
